{"id":"W2960195497","doi":"10.1016/j.jchf.2019.05.015","title":"Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction","year":2019,"lang":"en","type":"article","venue":"JACC Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Janssen Pharmaceuticals; National Heart, Lung, and Blood Institute; National Medical Research Council; Baxter Healthcare Corporation; GE Healthcare; National Center for Advancing Translational Sciences; Johnson and Johnson; Gilead Sciences; Servier; MyoKardia; Novo Nordisk; Seventh Framework Programme; Daiichi-Sankyo; Bayer Fund; Cytokinetics; Boston Scientific Corporation; Agence Nationale de la Recherche; Roche; Novartis; European Commission; Sanofi; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Vifor Pharma; Pfizer; Bristol-Myers Squibb; AstraZeneca; National Institutes of Health; Medtronic","keywords":"Medicine; Heart failure; Valsartan; Ejection fraction; Clinical trial; Randomization; Internal medicine; Heart failure with preserved ejection fraction; Quality of life (healthcare); Sacubitril; Cardiology; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001317859,0.0004189334,0.0006591449,0.0009883521,0.0004363271,0.0009535358,0.0004567931,0.0007108898,0.001738869],"category_scores_gemma":[0.002786694,0.0001505022,0.001125217,0.0008170413,0.000359616,0.0008409779,0.001154508,0.001042812,0.0001841435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005120516,"about_ca_system_score_gemma":0.0003219279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003333894,"about_ca_topic_score_gemma":0.005173502,"domain_scores_codex":[0.9993827,0.0002262843,0.00006396731,0.00005722935,0.00008927244,0.000180497],"domain_scores_gemma":[0.9988534,0.0002228174,0.0003661379,0.00003447154,0.0001236323,0.0003994925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006657353,0.0002532304,0.9899093,0.00006878106,0.0003953482,0.0001524171,0.00009271096,0.0002058833,0.0001245932,0.00007109176,0.0003719772,0.007688832],"study_design_scores_gemma":[0.00002352693,0.0002874683,0.9987822,0.00002006802,0.00007543589,0.00009873888,0.0001507588,0.0002887573,0.00002045391,0.0001003843,0.0001463062,0.000005886222],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956031,0.00186578,0.0001049494,0.0003248335,0.00004818444,0.00001563139,0.0005614904,0.000003273637,0.001472744],"genre_scores_gemma":[0.9988674,0.0002603464,0.00005797806,0.00008038923,0.0000412734,0.000009242324,0.0005211608,8.519842e-7,0.0001613713],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003333894,"threshold_uncertainty_score":0.006969571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02481825569405591,"score_gpt":0.2975866812743614,"score_spread":0.2727684255803055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}